Hans‐Georg Posselt

1.2k total citations
38 papers, 808 citations indexed

About

Hans‐Georg Posselt is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, Hans‐Georg Posselt has authored 38 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 9 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Hans‐Georg Posselt's work include Cystic Fibrosis Research Advances (19 papers), Child Nutrition and Feeding Issues (4 papers) and Antibiotic Resistance in Bacteria (4 papers). Hans‐Georg Posselt is often cited by papers focused on Cystic Fibrosis Research Advances (19 papers), Child Nutrition and Feeding Issues (4 papers) and Antibiotic Resistance in Bacteria (4 papers). Hans‐Georg Posselt collaborates with scholars based in Germany, Switzerland and United States. Hans‐Georg Posselt's co-authors include S. W. Bender, Félix Ratjen, Joachim Bargon, H. Skopnik, Gerhard Haase, G. Kusenbach, Barbara Braden, Wolfgang F. Caspary, Benedikt Köhler and Gemma Comes and has published in prestigious journals such as Gastroenterology, PEDIATRICS and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Hans‐Georg Posselt

36 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans‐Georg Posselt Germany 14 463 176 141 137 102 38 808
Héctor Escobar Spain 12 272 0.6× 85 0.5× 200 1.4× 117 0.9× 92 0.9× 33 578
Mary Corey Canada 14 791 1.7× 154 0.9× 213 1.5× 90 0.7× 78 0.8× 21 1.0k
Nicholas J. Simmonds United Kingdom 19 941 2.0× 167 0.9× 141 1.0× 103 0.8× 96 0.9× 73 1.1k
M B Mearns United Kingdom 17 819 1.8× 115 0.7× 67 0.5× 101 0.7× 57 0.6× 25 1.0k
T. Pressler Denmark 13 406 0.9× 62 0.4× 76 0.5× 25 0.2× 179 1.8× 28 614
Dan Kottachchi Canada 6 97 0.2× 108 0.6× 77 0.5× 101 0.7× 136 1.3× 10 536
A Penketh United Kingdom 15 636 1.4× 323 1.8× 230 1.6× 54 0.4× 107 1.0× 23 971
Arvey I. Rogers United States 18 174 0.4× 482 2.7× 140 1.0× 42 0.3× 65 0.6× 75 979
Anna Zolin Italy 15 703 1.5× 86 0.5× 118 0.8× 47 0.3× 111 1.1× 29 1.0k
Allan Walker United States 9 84 0.2× 87 0.5× 154 1.1× 73 0.5× 180 1.8× 12 676

Countries citing papers authored by Hans‐Georg Posselt

Since Specialization
Citations

This map shows the geographic impact of Hans‐Georg Posselt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Georg Posselt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Georg Posselt more than expected).

Fields of papers citing papers by Hans‐Georg Posselt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans‐Georg Posselt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Georg Posselt. The network helps show where Hans‐Georg Posselt may publish in the future.

Co-authorship network of co-authors of Hans‐Georg Posselt

This figure shows the co-authorship network connecting the top 25 collaborators of Hans‐Georg Posselt. A scholar is included among the top collaborators of Hans‐Georg Posselt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans‐Georg Posselt. Hans‐Georg Posselt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koningsbruggen‐Rietschel, Silke van, Hans‐Georg Posselt, Doris Staab, et al.. (2015). Pharmacokinetics and safety of an 8 week continuous treatment with once-daily versus twice-daily inhalation of tobramycin in cystic fibrosis patients. Journal of Antimicrobial Chemotherapy. 71(3). 711–717. 11 indexed citations
2.
Hebestreit, Helge, Sibylle Junge, Manfred Ballmann, et al.. (2014). Quality of life is associated with physical activity and fitness in cystic fibrosis. BMC Pulmonary Medicine. 14(1). 26–26. 106 indexed citations
3.
Rietschel, E., et al.. (2010). Pharmacokinetics of continuous treatment with o.d. or b.i.d. inhalation of tobramycin (TOBI™). Journal of Cystic Fibrosis. 9. S23–S23. 8 indexed citations
4.
Posselt, Hans‐Georg, et al.. (2008). Bildgebung bei zystischer Fibrose. 8(2). 159–177. 1 indexed citations
5.
Gerner, Patrick, Hans‐Georg Posselt, Andreas Krahl, et al.. (2008). Vitamin E treatment for children with chronic hepatitis B: A randomized placebo controlled trial. World Journal of Gastroenterology. 14(47). 7208–7208. 14 indexed citations
6.
Santer, René, Johannes Rischewski, Sonja Schneppenheim, et al.. (2005). The spectrum of aldolase B (ALDOB) mutations and the prevalence of hereditary fructose intolerance in Central Europe. Human Mutation. 25(6). 594–594. 46 indexed citations
7.
Gerner, Patrick, Hans‐Georg Posselt, Antje Ballauff, et al.. (2004). P0335 VITAMIN E AS TREATMENT FOR CHRONIC HEPATITIS B IN CHILDHOOD: RESULTS OF A RANDOMISED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED TRIAL. Journal of Pediatric Gastroenterology and Nutrition. 39(S1). 1 indexed citations
8.
Posselt, Hans‐Georg, et al.. (2002). Effekte einer âoptimiertenâ Bewegungstherapie auf die Leistungsfähigkeit bei Patienten mit Cystischer Fibrose. Pneumologie. 56(9). 542–546. 3 indexed citations
9.
Ratjen, Félix, et al.. (2001). Effect of continuous antistaphylococcal therapy on the rate ofP. aeruginosa acquisition in patients with cystic fibrosis. Pediatric Pulmonology. 31(1). 13–16. 95 indexed citations
10.
Braden, Barbara, Hans‐Georg Posselt, Peter Ahrens, et al.. (2000). New Immunoassay in Stool Provides an Accurate Noninvasive Diagnostic Method forHelicobacter pyloriScreening in Children. PEDIATRICS. 106(1). 115–117. 77 indexed citations
11.
Braden, Barbara, Hans‐Georg Posselt, Peter Ahrens, et al.. (2000). New immunassay in stool provides an accurate non-invasive diagnostic method for Helicobacter pylori screening in children. Gastroenterology. 118(4). A503–A503. 1 indexed citations
12.
Bargon, Joachim, Nurlan Dauletbaev, Benedikt Köhler, et al.. (1999). Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonization in adult cystic fibrosis patients. Respiratory Medicine. 93(11). 835–838. 85 indexed citations
13.
Krackhardt, B., et al.. (1997). Ultrasound Studies of the Intestinal Wall in Patients with Cystic Fibrosis. Journal of Pediatric Gastroenterology and Nutrition. 25(3). 317–320.
14.
Reiss, Jochen, et al.. (1993). Two cystic fibrosis patients with the genotype G542X/G551D. Human Genetics. 91(1). 78–9. 1 indexed citations
15.
Reiss, Jochen, et al.. (1992). A novel CFTR mutation, 4035delA, detected by non-radioactive SSCP analysis. Human Genetics. 90(3). 303–4. 4 indexed citations
16.
Reis, André, Manfred Schlösser, J. Hundrieser, et al.. (1990). Distribution patterns of the ΔF508 mutation in the CFTR gene on CF-linked marker haplotypes in the German population. Human Genetics. 85(4). 421–422. 10 indexed citations
17.
Posselt, Hans‐Georg, et al.. (1988). Ectopic Gastric Mucosa in Rectum. Journal of Pediatric Gastroenterology and Nutrition. 7(2). 293–297. 1 indexed citations
18.
Posselt, Hans‐Georg, et al.. (1988). Ectopic Gastric Mucosa in Rectum. Journal of Pediatric Gastroenterology and Nutrition. 7(2). 293–297. 10 indexed citations
19.
Bender, S. W., et al.. (1986). Ciprofloxacin pharmacokinetics in patients with cystic fibrosis. Infection. 14(1). 17–21. 29 indexed citations
20.
Green, Jonathan R., S. W. Bender, Hans‐Georg Posselt, & Michael J. Lentze. (1984). Primary Intestinal Enteropeptidase Deficiency. Journal of Pediatric Gastroenterology and Nutrition. 3(4). 630–633. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Héctor Escobar Breakdown of academic impact, for papers by Mary Corey Breakdown of academic impact, for papers by Nicholas J. Simmonds Breakdown of academic impact, for papers by M B Mearns Breakdown of academic impact, for papers by T. Pressler Breakdown of academic impact, for papers by Dan Kottachchi Breakdown of academic impact, for papers by A Penketh Breakdown of academic impact, for papers by Arvey I. Rogers Breakdown of academic impact, for papers by Anna Zolin Breakdown of academic impact, for papers by Allan Walker
Rankless by CCL
2026